ASX:API Australian Pharmaceutical Industries (API) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Australian Pharmaceutical Industries Stock (ASX:API) 30 days 90 days 365 days Advanced Chart Get API alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume453,647 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield2.29%Price TargetN/AConsensus RatingN/A Company OverviewAustralian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia.Read More… Receive API Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Australian Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. Email Address API Stock News HeadlinesChemist Warehouse price rise warning after $8.8 billon deal greenlit: 'We will rue this day'November 7, 2024 | nz.finance.yahoo.comACCC clears Chemist Warehouse and Sigma’s $8.8b mega dealNovember 6, 2024 | msn.comA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.June 6, 2025 | American Alternative (Ad)Nasdaq Wrap: Reddit notches first ever profit; while an Aussie company leads Nasdaq’s winnersNovember 6, 2024 | msn.comCaliway Completed CBL-514 Phase 2b Study (CBL-0205) for Subcutaneous Fat ReductionOctober 24, 2024 | finance.yahoo.comElon Musk's xAI launched its own APIOctober 22, 2024 | msn.comM&A in the Pharma Contract Manufacturing Industry: 2024 Trends, Implications and OutlookOctober 4, 2024 | finance.yahoo.comFrost & Sullivan Released Report: "2024 Blue Book on Chinese Biopharmaceuticals Going Global: Current Status and Trends"September 28, 2024 | au.finance.yahoo.comSee More Headlines API Stock Analysis - Frequently Asked Questions How were Australian Pharmaceutical Industries' earnings last quarter? Australian Pharmaceutical Industries Limited (ASX:API) released its earnings results on Wednesday, April, 17th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by $0.00. What other stocks do shareholders of Australian Pharmaceutical Industries own? Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY) and Global X Cloud Computing ETF (CLOU). Company Calendar Last Earnings4/17/2019Today6/06/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorBusiness Services Industry Medical Equipment Wholesale Sub-IndustryComputer Software Current SymbolASX:API CIKN/A Webwww.api.net.au Phone+61-3-88553000FaxN/AEmployees1,310Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.28Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio71.32 Current Ratio1.20 Quick Ratio0.77 Sales & Book Value Annual Sales$4.00 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow8.26 Book ValueA$0.89 per share Price / BookN/AMiscellaneous Outstanding Shares492,656,000Free FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (ASX:API) was last updated on 6/6/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhy hasn't Elon tweeted about this?Behind the scenes, there's an entirely different Tesla story brewing… . It's about a quiet stream of income...Investors Alley | SponsoredThe Real Reason Silver Prices Are SoaringElon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major shift is coming this July — and Wall Street isn't waiting around. Thanks to a new rule going into e...American Alternative | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Australian Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Australian Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.